Learning Objectives:

  1. To overview of brain tumor and the challenges in drug development for malignant gliomas
  2. Using the development of zotiraciclib as an example to demonstrate the importance of preclinical studies in drug development
  3. Learning from the clinical findings for further preclinical investigation.
Session date: 
12/09/2021 - 7:30am to 8:30am CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jing Wu, MD, PhD